Vigil Neuroscience, Inc.
VIGL
$1.77
$0.095.36%
| Weiss Ratings | VIGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | VIGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | VIGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.19 | |||
| Price History | VIGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -6.84% | |||
| 30-Day Total Return | -37.89% | |||
| 60-Day Total Return | -3.28% | |||
| 90-Day Total Return | -41.78% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -46.77% | |||
| 2-Year Total Return | -81.03% | |||
| 3-Year Total Return | -75.31% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -72.28% | |||
| 52-Week Low % Change | 12.75% | |||
| Price | VIGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $6.06 | |||
| 52-Week Low Price | $1.49 | |||
| 52-Week Low Price (Date) | Dec 30, 2024 | |||
| 52-Week High Price (Date) | Jun 07, 2024 | |||
| Valuation | VIGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 78.41M | |||
| Enterprise Value | -6.44M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -2.07 | |||
| Earnings Per Share Growth | -3.01% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.96 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $1.77 | |||
| Enterprise Value/EBITDA (TTM) | 0.07 | |||
| Enterprise Value/EBIT | 0.07 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | VIGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 41.66M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | VIGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 857 254 4445 | |||
| Address | 100 Forge Road Watertown, MA 02472 | |||
| Website | www.vigilneuro.com | |||
| Country | United States | |||
| Year Founded | 2020 | |||
| Profitability | VIGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | VIGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -43.36% | |||
| Return on Equity | -- | |||
| Income Statement | VIGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -89.23M | |||
| EBIT (TTM) | -89.68M | |||
| Net Income (TTM) | -84.26M | |||
| Net Income Avl. to Common (TTM) | -84.26M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -7.47% | |||
| EPS Diluted (TTM) | -2.07 | |||
| EPS Diluted Growth (Q YOY) | -0.18% | |||
| Balance Sheet | VIGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 97.80M | |||
| Cash Per Share (Q) | $2.35 | |||
| Total Current Assets (Q) | 100.58M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 71.64M | |||
| Current Ratio (Q) | 2.946 | |||
| Book Value Per Share (Q) | $1.75 | |||
| Total Assets (Q) | 117.69M | |||
| Total Current Liabilities (Q) | 34.15M | |||
| Total Debt (Q) | 12.95M | |||
| Total Liabilities (Q) | 46.06M | |||
| Total Common Equity (Q) | 71.64M | |||
| Cash Flow | VIGL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 8.76M | |||
| Cash from Financing (TTM) | 29.49M | |||
| Net Change in Cash (TTM) | -12.97M | |||
| Levered Free Cash Flow (TTM) | -21.95M | |||
| Cash from Operations (TTM) | -51.22M | |||
